|
1
|
Caplan AI: Mesenchymal stem cells. J
Orthop Res. 9:641–650. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crisan M, Yap S, Casteilla L, Chen CW,
Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al: A
perivascular origin for mesenchymal stem cells in multiple human
organs. Cell Stem Cell. 3:301–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryu KH, Cho KA, Park HS, Kim JY, Woo SY,
Jo I, Choi YH, Park YM, Jung SC, Chung SM, et al: Tonsil-derived
mesenchymal stromal cells: Evaluation of biologic, immunologic and
genetic factors for successful banking. Cytotherapy. 14:1193–1202.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oh SY, Choi YM, Kim HY, Park YS, Jung SC,
Park JW, Woo SY, Ryu KH, Kim HS and Jo I: Application of
tonsil-derived mesenchymal stem cells in tissue regeneration:
Concise review. Stem Cells. 37:1252–1260. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho KA, Park M, Kim YH, Woo SY and Ryu KH:
RNA sequencing reveals a transcriptomic portrait of human
mesenchymal stem cells from bone marrow, adipose tissue, and
palatine tonsils. Sci Rep. 7:171142017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JY, Park M, Kim YH, Ryu KH, Lee KH,
Cho KA and Woo SY: Tonsil-derived mesenchymal stem cells (T-MSCs)
prevent Th17-mediated autoimmune response via regulation of the
programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
J Tissue Eng Regen Med. 12:e1022–e1033. 2018. View Article : Google Scholar
|
|
7
|
Caplan AI and Correa D: The MSC: An injury
drugstore. Cell Stem Cell. 9:11–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andrzejewska A, Lukomska B and Janowski M:
Concise review: Mesenchymal stem cells: From roots to boost. Stem
Cells. 37:855–864. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gnecchi M, He H, Liang OD, Melo LG,
Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS and Dzau
VJ: Paracrine action accounts for marked protection of ischemic
heart by Akt-modified mesenchymal stem cells. Nat Med. 11:367–368.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goolaerts A, Pellan-Randrianarison N,
Larghero J, Vanneaux V, Uzunhan Y, Gille T, Dard N, Planès C,
Matthay MA and Clerici C: Conditioned media from mesenchymal
stromal cells restore sodium transport and preserve epithelial
permeability in an in vitro model of acute alveolar injury. Am J
Physiol Lung Cell Mol Physiol. 306:L975–L985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extra-cellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar
|
|
12
|
Nakamura Y, Miyaki S, Ishitobi H,
Matsuyama S, Nakasa T, Kamei N, Akimoto T, Higashi Y and Ochi M:
Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle
regeneration. FEBS Lett. 589:1257–1265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asgarpour K, Shojaei Z, Amiri F, Ai J,
Mahjoubin-Tehran M, Ghasemi F, ArefNezhad R, Hamblin MR and Mirzaei
H: Exosomal microRNAs derived from mesenchymal stem cells:
Cell-to-cell messages. Cell Commun Signal. 18:1492020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mathivanan S, Fahner CJ, Reid GE and
Simpson RJ: ExoCarta 2012: Database of exosomal proteins, RNA and
lipids. Nucleic Acids Res. 40(Database Issue): D1241–D1244. 2012.
View Article : Google Scholar :
|
|
15
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balkwill FR, Capasso M and Hagemann T: The
tumor microenvironment at a glance. J Cell Sci. 125:5591–5596.
2012. View Article : Google Scholar
|
|
17
|
Keshtkar S, Azarpira N and Ghahremani MH:
Mesenchymal stem cell-derived extracellular vesicles: Novel
frontiers in regenerative medicine. Stem Cell Res Ther. 9:632018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bruno S, Collino F, Deregibus MC, Grange
C, Tetta C and Camussi G: Microvesicles derived from human bone
marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev.
22:758–771. 2013. View Article : Google Scholar
|
|
19
|
Alzahrani FA, El-Magd MA,
Abdelfattah-Hassan A, Saleh AA, Saadeldin IM, El-Shetry ES, Badawy
AA and Alkarim S: Potential effect of exosomes derived from cancer
stem cells and MSCs on progression of DEN-induced HCC in rats. Stem
Cells Int. 2018:80589792018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim YH, Cho KA, Lee HJ, Park M, Shin SJ,
Park JW, Woo SY and Ryu KH: Conditioned medium from human
tonsil-derived mesenchymal stem cells enhances bone marrow
engraftment via endothelial cell restoration by pleiotrophin.
Cells. 9:2212020. View Article : Google Scholar :
|
|
21
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar
|
|
22
|
Ramsköld D, Luo S, Wang YC, Li R, Deng Q,
Faridani OR, Daniels GA, Khrebtukova I, Loring JF, Laurent LC, et
al: Full-length mRNA-Seq from single-cell levels of RNA and
individual circulating tumor cells. Nat Biotechnol. 30:777–782.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Cho KA, Kim YH, Park M, Kim HJ, Woo SY,
Park JW and Ryu KH: Conditioned medium from human palatine tonsil
mesenchymal stem cells attenuates acute graft-vs-host disease in
mice. Mol Med Rep. 19:609–616. 2019.
|
|
25
|
Cho KA, Lee JK, Kim YH, Park M, Woo SY and
Ryu KH: Mesenchymal stem cells ameliorate B-cell-mediated immune
responses and increase IL-10-expressing regulatory B cells in an
EBI3-dependent manner. Cell Mol Immunol. 14:895–908. 2017.
View Article : Google Scholar :
|
|
26
|
Poupardin R, Wolf M and Strunk D:
Adherence to minimal experimental requirements for defining
extracellular vesicles and their functions. Adv Drug Deliv Rev.
176:1138722021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferreira JR, Teixeira GQ, Santos SG,
Barbosa MA, Almeida-Porada G and Gonçalves RM: Mesenchymal stromal
cell secretome: Influencing therapeutic potential by cellular
pre-conditioning. Front Immunol. 9:28372018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tahamtan A, Teymoori-Rad M, Nakstad B and
Salimi V: Anti-inflammatory MicroRNAs and their potential for
inflammatory diseases treatment. Front Immunol. 9:13772018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suárez Y and Sessa WC: MicroRNAs as novel
regulators of angiogenesis. Circ Res. 104:442–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu H, Ji R, Zhang X, Wang M, Zhu W, Qian
H, Chen Y, Jiang P and Xu W: Exosomes derived from human
mesenchymal stem cells promote gastric cancer cell growth and
migration via the activation of the Akt pathway. Mol Med Rep.
14:3452–3458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu P, Zhang B, Shi H, Qian H and Xu W:
MSC-exosome: A novel cell-free therapy for cutaneous regeneration.
Cytotherapy. 20:291–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ferguson SW, Wang J, Lee CJ, Liu M,
Neelamegham S, Canty JM and Nguyen J: The microRNA regulatory
landscape of MSC-derived exosomes: A systems view. Sci Rep.
8:14192018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao R, Chen X, Song H, Bie Q and Zhang B:
Dual role of MSC-derived exosomes in tumor development. Stem Cells
Int. 2020:88447302020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Christodoulou I, Goulielmaki M, Devetzi M,
Panagiotidis M, Koliakos G and Zoumpourlis V: Mesenchymal stem
cells in preclinical cancer cytotherapy: A systematic review. Stem
Cell Res Ther. 9:3362018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vallabhaneni KC, Penfornis P, Dhule S,
Guillonneau F, Adams KV, Mo YY, Xu R, Liu Y, Watabe K, Vemuri MC
and Pochampally R: Extracellular vesicles from bone marrow
mesenchymal stem/stromal cells transport tumor regulatory microRNA,
proteins, and metabolites. Oncotarget. 6:4953–4967. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takahara K, Ii M, Inamoto T, Nakagawa T,
Ibuki N, Yoshikawa Y, Tsujino T, Uchimoto T, Saito K, Takai T, et
al: microRNA-145 mediates the inhibitory effect of adipose
tissue-derived stromal cells on prostate cancer. Stem Cells Dev.
25:1290–1298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cai QQ, Dong YW, Wang R, Qi B, Guo JX, Pan
J, Liu YY, Zhang CY and Wu XZ: MiR-124 inhibits the migration and
invasion of human hepatocellular carcinoma cells by suppressing
integrin αV expression. Sci Rep. 7:407332017. View Article : Google Scholar
|
|
38
|
Cui Y, Wu F, Tian D, Wang T, Lu T, Huang
X, Zhang P and Qin L: miR-199a-3p enhances cisplatin sensitivity of
ovarian cancer cells by targeting ITGB8. Oncol Rep. 39:1649–1657.
2018.PubMed/NCBI
|
|
39
|
Hemler ME: Tetraspanin functions and
associated microdomains. Nat Rev Mol Cell Biol. 6:801–811. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumari S, Devi GV, Badana A, Dasari VR and
Malla RR: CD151-A striking marker for cancer therapy. Biomark
Cancer. 7:7–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zijlstra A, Lewis J, Degryse B, Stuhlmann
H and Quigley JP: The inhibition of tumor cell intravasation and
subsequent metastasis via regulation of in vivo tumor cell motility
by the tetraspanin CD151. Cancer Cell. 13:221–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Winterwood NE, Varzavand A, Meland MN,
Ashman LK and Stipp CS: A critical role for tetraspanin CD151 in
alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions
on laminin-5. Mol Biol Cell. 17:2707–2721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zevian SC, Johnson JL, Winterwood NE,
Walters KS, Herndon ME, Henry MD and Stipp CS: CD151 promotes α3β1
integrin-dependent organization of carcinoma cell junctions and
restrains collective cell invasion. Cancer Biol Ther. 16:1626–1640.
2015. View Article : Google Scholar
|
|
44
|
Peng D, Li PC, Liu T, Zeng HS, Fei YJ, Liu
ZX and Zuo HJ: Key role of CD151-integrin complex in lung cancer
metastasis and mechanisms involved. Curr Med Sci. 40:1148–1155.
2020. View Article : Google Scholar
|
|
45
|
You B, Xu W and Zhang B: Engineering
exosomes: A new direction for anticancer treatment. Am J Cancer
Res. 8:1332–1342. 2018.PubMed/NCBI
|
